Ritonavir Antiretroviral Aids
Mostrando 1-12 de 15 artigos, teses e dissertações.
-
1. Estudo dos problemas farmacolÃgicos em pacientes HIV+ sob terapia antirretroviral inicial em um Centro de Especialidades MÃdicas de Fortaleza-CearÃ. / Pharmacological study of problems in HIV+ patients under antiretroviral therapy early in a Center of Medical Specialties in Fortaleza, CearÃ.
A sÃndrome de imunodeficiÃncia adquirida (AIDS) à causada pela infecÃÃo pelo HIV e jà nÃo à sinÃnimo de letalidade. Desde que a doenÃa foi descoberta, no inÃcio da dÃcada de 1980, muitos avanÃos foram dados em relaÃÃo à maior compreensÃo da doenÃa e desenvolvimento terapÃutico. Atualmente, uma combinaÃÃo de medicamentos conhecida como HA
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 23/09/2011
-
2. Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
This study evaluated the effectiveness of two HAART regimens concomitant to rifampicin based tuberculosis (TB) treatment. Patients with TB/HIV diagnosis followed at the TB program between June 2000 and March 2005 were prospectively evaluated. The different HAART regimens in antiretrovirals (ARV) treatment naïve and ARV experienced patients were compared. Th
Brazilian Journal of Infectious Diseases. Publicado em: 2009-10
-
3. Evaluation of HIV/AIDS patients' knowledge on antiretroviral drugs
Lack of information on antiretroviral drugs or the misunderstanding of available information can facilitate incorrect use of such drugs. This can result in non-adherence to the prescribed regimen, leading to a great possibility of a therapeutic failure. The aim of this study was to know which information HIV/AIDS patients, who receive their medicines at the
Brazilian Journal of Infectious Diseases. Publicado em: 2009-06
-
4. Lesões anorretais em pacientes HIV positivos usuários de terapia anti-retroviral de alta efetividade
As lesões anorretais são comuns nos pacientes positivos para o vírus da imunodeficiência humana. A terapia antirretroviral de alta efetividade tem pouca influência na progressão das neoplasias anais. Estudou-se a prevalência das lesões anorretais em 88 pacientes HIV positivos atendidos no serviço de doenças infecto-parasitárias do Hospital Univers
Revista da Sociedade Brasileira de Medicina Tropical. Publicado em: 2007-06
-
5. Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
Antiretroviral therapy has been associated with hyperlipidemia in AIDS patients. This case illustrates the classic metabolic effects associated to the HAART including protease inhibitors and/or stavudine. It was showed that the management of the HAART-associated dyslipidaemia with conventional antihyperlipidemic therapy may fail, being the switching strategy
Brazilian Journal of Infectious Diseases. Publicado em: 2007-04
-
6. Self-reported adverse reactions among patients initiating antiretroviral therapy in Brazil
A cross-sectional analysis was carried out to describe adverse reactions to antiretroviral therapy (ART) reported by HIV-infected patients initiating treatment at two public health AIDS referral centers in Belo Horizonte, Brazil, 2001-2003 and to verify their association with selected variables. Adverse reactions were obtained through interview at the first
Brazilian Journal of Infectious Diseases. Publicado em: 2007-02
-
7. Avaliação da duração e impacto do primeiro esquema anti-retroviral altamente potente em pacientes portadores da Síndrome da Imunodeficiência Adquirida (SIDA) em acompanhamento no Setor de Imunodeficiências do Serviço de Doenças Infecciosas e Parasitárias/ Hospital das Clínicas (DIP/HC) do Centro de Treinamento e Referência em Doenças Infecciosas e Parasitárias Orestes Diniz (CTR-DIP/UFMG-PBH) em Belo Horizonte, Minas Gerais.
The highly active antiretroviral therapy (HAART) improves substantially the prognosis of HIV infected patients. Finding a better regimen for the first antiretroviral treatment is one of the strategies used to improve time and quality of life of people living with HIV/AIDS. A total of 891 HIV infected patients assisted at the CTR-DIP Orestes Diniz and treated
Publicado em: 2007
-
8. High incidence of adverse reactions to initial antiretroviral therapy in Brazil
A concurrent prospective study was conducted from 2001 to 2003 to assess factors associated with adverse reactions among individuals initiating antiretroviral therapy at two public referral HIV/AIDS centers in Belo Horizonte, MG, Brazil. Adverse reactions were obtained from medical charts reviewed up to 12 months after the first antiretroviral prescription.
Brazilian Journal of Medical and Biological Research. Publicado em: 2006-04
-
9. Efeitos metabólicos associados à terapia anti-retroviral potente em pacientes com Aids
Este estudo teve como objetivo avaliar as anormalidades metabólicas - dislipidemia , resistência à insulina e lipodistrofia que constituem a Síndrome Lipodistrófica, associada à terapia anti-retroviral potente (HAART) em pacientes com a Síndrome da Imunodeficiência Adquirida (AIDS) tratados em Campo Grande, Mato Grosso do Sul, Brasil. Inicialmente, p
Publicado em: 2006
-
10. Alterações no metabolismo lipídico e glicídico de crianças portadoras de HIV/aids atendidas na Unidade Mista de Saúde da Regional Sul (Hospital Dia) no Distrito Federal, Brasil
The implementation of Highly Active Antiretroviral Therapy (HAART) in combination regimens has profoundly decreased mortality and disease progression in children infected with the human immunodeficiency virus. These, however, are more vulnerable for the adverse effects of the therapy because they must be treated for a long time. The metabolic effects of the
Publicado em: 2006
-
11. Soft technology of verbal attainment of solution and capsules the base of Ritonavir / Tecnologia de obtenÃÃo de soluÃÃo oral e cÃpsulas moles a base de Ritonavir
O ritonavir, aprovado pelo FDA (Food and Drug Administration â agÃncia americana que regulamenta drogas e alimentos) em marÃo de 1996 nas formas farmacÃuticas soluÃÃo oral 80 mg/mL e cÃpsula mole 100 mg, Ã um inibidor da protease (IP) do vÃrus da imunodeficiÃncia humana (HIV), voltado exclusivamente para o tratamento da SÃndrome da ImunodeficiÃnc
Publicado em: 2004
-
12. Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are the causative agents of AIDS. HIV-2 is prevalent at moderate to high rates in West African countries, such as Senegal, Guinea, Gambia, and Cape Verde. Diagnosis of HIV-2 is made with a positive HIV-1/HIV-2 ELISA or simple/rapid assay, followed by one or two confirmatory tests specific for HIV
Brazilian Journal of Infectious Diseases. Publicado em: 2003-02